Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05547984

Ceramic Modular Dual Mobility in Primary Total Hip Arthroplasty (THA)

A Randomized Controlled Trial Comparing Modular Dual Mobility Inserts With Ceramic Multilayer Coating Versus Standard Polyethylene Inserts for Primary Total Hip Arthroplasty (THA) in a Cementless Acetabular Cup

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Aesculap AG · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A randomized controlled trial comparing modular dual mobility inserts with ceramic multilayer coating versus standard polyethylene inserts for primary THA in a cementless acetabular cup

Detailed description

The aim of this study is to show in a randomized controlled trial that cobalt and chromium ion serum levels are comparable to the metal ion levels in patients with standard articulation with metal head. The metal on polyethylene articulation is accepted as standard articulation since many decades, and which is currently in the Czech Republic the most used combination. Most studies which focused on the topic of metal ion release from modular dual mobility systems do not present results of a control group with standard articulation hip implants.

Conditions

Interventions

TypeNameDescription
DEVICEDual Mobility CupTotal hip arthroplasty (THA) is a successful and established therapy for coxarthrosis, rheumatic arthritis, hip fractures and femoral head necrosis. The acetabular implant for this arm is the Dual Mobility cup
DEVICEStandard Acetabular componentTotal hip arthroplasty (THA) is a successful and established therapy for coxarthrosis, rheumatic arthritis, hip fractures and femoral head necrosis. The acetabular implant for this arm is the standard device with polyethylene + vitamin E inlay and metal head

Timeline

Start date
2022-11-21
Primary completion
2027-09-01
Completion
2028-08-01
First posted
2022-09-21
Last updated
2025-12-16

Locations

1 site across 1 country: Czechia

Source: ClinicalTrials.gov record NCT05547984. Inclusion in this directory is not an endorsement.